Related references
Note: Only part of the references are listed.Mechanisms and interactions in concomitant use of herbs and warfarin therapy: An updated review
Paula Mendonca Leite et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Empowerment-oriented strategies to identify behavior change in patients with chronic diseases: An integrative review of the literature
Hannah Cardoso Barbosa et al.
PATIENT EDUCATION AND COUNSELING (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Inter-observer reliability of a risk assessment model for venous thromboembolism in acutely-ill medical hospitalized patients: Results from a prospective cohort study
Cassia R. L. Ferreira et al.
PHLEBOLOGY (2021)
Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation
Sylvie Perreault et al.
PHARMACOTHERAPY (2020)
Self-reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants
Myrthe M. A. Toorop et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?
Lin-Lu Ma et al.
MILITARY MEDICAL RESEARCH (2020)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
A survey of reasons for continuing warfarin therapy in the era of direct oral anticoagulants in Japanese patients with atrial fibrillation: the SELECT study
Takanori Ikeda et al.
PATIENT PREFERENCE AND ADHERENCE (2018)
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis (vol 359, j5058, 2017)
Jose A. Lopez-Lopez et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis (vol 359, j5058, 2017)
Jose A. Lopez-Lopez et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
Clara L. Rodriguez-Bernal et al.
Journal of Managed Care & Specialty Pharmacy (2018)
Drug Adherence in Patients With Nonvalvular Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants in Turkey: NOAC-TR
Sadik Volkan Emren et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
Factors associated with antihypertensive medication non-adherence: a systematic review
D. M. van der Laan et al.
JOURNAL OF HUMAN HYPERTENSION (2017)
Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China
Shujuan Zhao et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
Computation of adherence to medication and visualization of medication histories in R with AdhereR: Towards transparent and reproducible use of electronic healthcare data
Alexandra Lelia Dima et al.
PLOS ONE (2017)
Association Between Patient-Reported Medication Adherence and Anticoagulation Control
Jonathan Sevilla-Cazes et al.
AMERICAN JOURNAL OF MEDICINE (2017)
Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study
Nicolas Faller et al.
AMERICAN JOURNAL OF MEDICINE (2017)
Global Burden of Thrombosis Epidemiologic Aspects
Aaron M. Wendelboe et al.
CIRCULATION RESEARCH (2016)
Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation
Jan Beyer-Westendorf et al.
EUROPACE (2016)
US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014
Nadine Shehab et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
Agon Mekaj et al.
Therapeutics and Clinical Risk Management (2015)
Social Determinants of Health Equity
Michael Marmot et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2014)
The Costs of Warfarin Underuse and Nonadherence in Patients with Atrial Fibrillation: A Commercial Insurer Perspective
Julian P. Casciano et al.
JOURNAL OF MANAGED CARE PHARMACY (2013)
Oral Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Walter Ageno et al.
CHEST (2012)
Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
Hude Quan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
The Implications of Therapeutic Complexity on Adherence to Cardiovascular Medications
Niteesh K. Choudhry et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Risk factors for nonadherence to warfarin: results from the IN-RANGE study
Alec B. Platt et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Effect of warfarin nonadherence on control of the International Normalized Ratio
AD Waterman et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2004)
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature
JP Lacro et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Share Paper
